Literature DB >> 12900773

Tissue-restricted T cell alloresponses across HLA barriers: selection and identification of leukemia-restricted CTL in HLA-mismatched stimulator-responder pairs.

H Fujiwara1, G Sconocchia, J Melenhorst, R Eniafe, R Nakamura, N Hensel, A J Barrett.   

Abstract

Exploiting the graft-versus-leukemia (GVL) effect in mismatched transplants requires its separation from graft-versus-host disease (GVHD). We generated leukemia-specific cytotoxic T lymphocytes (CTL) in three haplotype-mismatched, two class I-mismatched and two single HLA-A locus-matched stimulator-responder pairs. Six patients with chronic myelogenous leukemia and one patient with acute myeloid leukemia transformed from MDS were studied. CTL generated after 10 days stimulation with unselected leukemic peripheral blood mononuclear cells inhibited leukemic CFU-GM colony growth (>85% at 10:1 effector:target ratio) with no third-party colony inhibition. In five pairs, responders were cultured separately with leukemia cells, PHA-B or LCL from the stimulator. After 2-4 restimulations, the T cell repertoire was examined by flow analysis using Vbeta-specific antibodies. Test cultures (but not controls) showed preferential expansion of 1-4 Vbeta families either common to two or more stimulators or unique to a particular stimulator. Notably, we elicited leukemia-specific TCR Vbeta expansions on four out of five occasions. In two pairs, responder cells selected for the appropriate leukemia-specific Vbeta family were shown to have leukemia-specific cytotoxicity. These leukemia-restricted T-cells were CD8+ or CD4+ and CD25+ or CD57+. The results support the development of strategies to selectively deplete GVHD and conserve GVL reactivity in mismatched transplants.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12900773     DOI: 10.1038/sj.bmt.1704142

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN: 0268-3369            Impact factor:   5.483


  4 in total

1.  Selectively T cell-depleted allografts from HLA-matched sibling donors followed by low-dose posttransplantation immunosuppression to improve transplantation outcome in patients with hematologic malignancies.

Authors:  Stephan Mielke; Zachariah A McIver; Aarthy Shenoy; Vicki Fellowes; Hahn Khuu; David F Stroncek; Susan F Leitman; Richard Childs; Minoo Battiwalla; Eleftheria Koklanaris; Janice Haggerty; Bipin N Savani; Katie Rezvani; A John Barrett
Journal:  Biol Blood Marrow Transplant       Date:  2011-05-31       Impact factor: 5.742

2.  Immune reconstitution in recipients of photodepleted HLA-identical sibling donor stem cell transplantations: T cell subset frequencies predict outcome.

Authors:  Zachariah A McIver; Jan J Melenhorst; Andrew Grim; Nicholas Naguib; Gerrit Weber; Vicki Fellowes; Hahn Khuu; David S Stroncek; Susan F Leitman; Minoo Battiwalla; A John Barrett
Journal:  Biol Blood Marrow Transplant       Date:  2011-05-30       Impact factor: 5.742

3.  Targeting T Cell Bioenergetics by Modulating P-Glycoprotein Selectively Depletes Alloreactive T Cells To Prevent Graft-versus-Host Disease.

Authors:  Zachariah A McIver; Jason M Grayson; Benjamin N Coe; Jacqueline E Hill; Gregory A Schamerhorn; Tymish Y Ohulchanskyy; Michelle K Linder; Kellie S Davies; Roy S Weiner; Michael R Detty
Journal:  J Immunol       Date:  2016-07-25       Impact factor: 5.422

4.  A new intensive conditioning regimen for allogeneic hematopoietic stem cell transplantation in patients with refractory or relapsed acute myeloid leukemia.

Authors:  Jingbo Wang; Jie Zhao; Xinhong Fei; Yuming Yin; Haoyu Cheng; Weijie Zhang; Jiangying Gu; Fan Yang; Yixin Yang; Song Xue; Zhengqin Tian; Junbao He; Shuqin Zhang; Xiaocan Wang
Journal:  Medicine (Baltimore)       Date:  2018-04       Impact factor: 1.889

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.